Tango Therapeutics, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.31 | — | — | Miss |
| Q12026 FY2026 | $-0.32 | $-0.32 | +0.0% | Beat |
| Q42025 FY2025 | $-0.31 | $-0.29 | +6.5% | Beat |
Back to TNGX overview · TNGX holders · TNGX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.